Spoken Alpha
Quantum Cyber N.V.
Quantum Cyber N.V. develops in-vitro diagnostic blood and stool tests for early detection of pancreatic cancer, having recently acquired exclusive rights to mRNA biomarkers and an AI algorithm for pancreatic cancer screening.
Quantum Cyber N.V is a Healthcare company operating in Diagnostics & Research with a $112.7M market cap.
QUCY beat consensus EPS by 0.1% in Q2 FY2026, reported Aug 13, 2026.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add QUCY, reply to your welcome email and we'll prioritize it.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for QUCY.
$ curl https://api.spokenalpha.com/v1/companies/QUCYFAQ
Spoken Alpha indexes QUCY's earnings call transcripts at https://spokenalpha.com/companies/QUCY. Each call links to attributed speakers and parsed analyst Q&A. Quantum Cyber N.V.'s own investor relations page is at https://quantum-cyber.ai/investors/stock-information.
Quantum Cyber N.V. (QUCY) operates in the Healthcare sector (Diagnostics & Research industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-13 | $-0.56 | $-0.63 | +11.1% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-28 | $-0.43 | — | — | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-04-08 | $-9.60 | $-12.40 | +22.6% | — | — | — | EODHD |
| Q3 FY2023 | 2023-11-15 | $-15.60 | $-19.60 | +20.4% | — | — | — | EODHD |
| Q2 FY2023 | 2023-08-14 | $-22.40 | $-13.80 | -62.3% | — | — | — | EODHD |
| Q1 FY2023 | 2023-05-15 | $-18.00 | $-18.80 | +4.3% | — | — | — | EODHD |
| Q3 FY2022 | 2022-11-02 | $-17.20 | $-17.20 | 0.0% | — | — | — | EODHD |
Source: EODHD. QUCY reported actuals as published; sparse fields render as —.